Novel markers, including neurofilament light chain (NfL) and oxysterols, are under investigation for NPC and GM2 gangliosidosis, with potential relevance to disease monitoring and progression, particularly in adult-onset phenotypes [103]. This evidence concerns the gene NEFL and GM2 gangliosidosis.